Russell Investments Group, Ltd.

Position in ANNX — Annexon, Inc.

CIK 1692234 Seattle, WA

Position in ANNX

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$3,941,041

+$512,304 QoQ

Shares Held

711,380

+4.2% QoQ

Ownership

0.356%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

9 quarters on record

Voting authority Sole 94.20337934718435.ToString("F0")% Shared 0.ToString("F0")% None 5.796620652815654.ToString("F0")%

Healthcare · as of Mar 31, 2026

Russell Investments Group, Ltd. holds $1,223,802,944 across 266 Biotechnology names. ANNX ranks #53 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	228,086	$176,228,356
2	VRTX	Vertex Pharmaceuticals Inc / Ma	367,691	$164,188,731
3	RPRX	Royalty Pharma plc	1,397,958	$67,060,041
4	INCY	Incyte Corp	638,242	$60,071,331
5	ALNY	Alnylam Pharmaceuticals, Inc.	147,533	$48,814,236
6	MRNA	Moderna, Inc.	710,640	$36,100,509
7	BMRN	Biomarin Pharmaceutical Inc	606,224	$34,245,589
8	INSM	INSMED Inc	169,162	$27,661,365

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,941,041	711,380	+4.2%	Shares	Other	2026-05-08
2025-12-31	$3,428,737	683,016	+3648.7%	Shares	Defined	2026-02-17
2025-09-30	$55,570	18,220	+1744.1%	Shares	Defined	2025-11-13
2024-12-31	$5,068	988	-5.8%	Shares	Defined	2025-02-13
2024-09-30	$6,210	1,049	-82.8%	Shares	Defined	2024-11-13
2024-06-30	$29,880	6,098	+517.2%	Shares	Defined	2024-08-08
2024-03-31	$7,083	988	0.0%	Shares	Defined	2024-05-08
2023-12-31	$4,485	988	0.0%	Shares	Defined	2024-02-05
2023-09-30	$2,331	988	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.